Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892569-04-000307
Filing Date
2004-03-05
Accepted
2004-03-05 06:03:14
Documents
11
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a96815e10vk.htm 10-K 1622182
3 EXHIBIT 3.6 a96815exv3w6.txt EX-3.6 1583
4 EXHIBIT 10.9 a96815exv10w9.txt EX-10.9 5702
5 EXHIBIT 10.12 a96815exv10w12.txt EX-10.12 29795
6 EXHIBIT 10.27 a96815exv10w27.txt EX-10.27 18483
7 EXHIBIT 10.29 a96815exv10w29.txt EX-10.29 8016
8 EXHIBIT 21 a96815exv21.txt EX-21 5018
9 EXHIBIT 23 a96815exv23.htm EX-23 2241
10 EXHIBIT 31.1 a96815exv31w1.htm EX-31.1 6446
11 EXHIBIT 31.2 a96815exv31w2.htm EX-31.2 6487
12 EXHIBIT 32 a96815exv32.htm EX-32 5919
  Complete submission text file 0000892569-04-000307.txt   1714490
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

EIN.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10269 | Film No.: 04650188
SIC: 2834 Pharmaceutical Preparations